FI113090B - Immunoanalyselement med stabila leukofärgöverdrag - Google Patents

Immunoanalyselement med stabila leukofärgöverdrag Download PDF

Info

Publication number
FI113090B
FI113090B FI954086A FI954086A FI113090B FI 113090 B FI113090 B FI 113090B FI 954086 A FI954086 A FI 954086A FI 954086 A FI954086 A FI 954086A FI 113090 B FI113090 B FI 113090B
Authority
FI
Finland
Prior art keywords
poly
layer
ligand
coating composition
labeled ligand
Prior art date
Application number
FI954086A
Other languages
English (en)
Finnish (fi)
Other versions
FI954086A0 (sv
FI954086A (sv
Inventor
John F Bishop
Linda A Mauck
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Publication of FI954086A0 publication Critical patent/FI954086A0/sv
Publication of FI954086A publication Critical patent/FI954086A/sv
Application granted granted Critical
Publication of FI113090B publication Critical patent/FI113090B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/969Multiple layering of reactants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/97Test strip or test slide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81Tube, bottle, or dipstick

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Paints Or Removers (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Claims (9)

1. Immunanalyselement, kännetecknat av att det omfattar ätminstone ett skikt som innehäller en 5 leukofärgämnebeteckningskomposition som omfattar: Komponent_Torrviktsförhällande (omrade) a) Triarylimidazolleuko- färgämne 55 - 80 10 b) Antioxidant 7-40 c) Poly[poly(etenoxid)block-poly- (propenoxid)]-icke-jonisk block-kopolymer 6 20 d) Alkylaryloxipoly(alkenoxid)- 15 icke-joniskt ytaktivt ämne 1-16
2. Analyselement för torrimmunanalys för bestäm-ning av en ligand, kännetecknat av att det omfattar i följande ordning (A) ett skikt som innehäller en märkt ligand, (B) ett utbredningsskikt av pärlor, 20 (C) ett tvärbindat, hydrofilt polymerskikt och (D) ett un- derlag, varvid ' (i) en fast koncentration av en receptor för den \ märkta liganden befinner sig i en zon (receptorzon) mellan : : gränsskiktet av skikt (B) och (C), ·· 25 (ii) receptorerna har immobiliserats genom att de : binds kovalent tili polymerpärlor som är mindre än pärlor- ·. na i skikt (B) , och (iii) nämnda zon omfattar även en leukofärgämnebe-;V# teckningskomposition som omfattar 30 * Komponent_ Torrviktsförhällande (omräde) t '.j a) Triarylimidazolleuko- i färgämne 55 - 80 . b) Antioxidant 7-40 35 c) Poly[poly(etenoxid)block-poly-(propenoxid)]-icke-jonisk block- 113090 kopolymer 6 20 d) Alkylaryloxipoly(alkenoxid)-icke-joniskt ytaktivt ämne 1-16
3. Analyselement av torrimmunanalys för bestämning 5 av en ligand, kännetecknat av att det omfattar i följande ordning (A) ett skikt som innehäller en märkt ligand, (B) ett utbredningsskikt av pärlor, (C) ett tvärbindat, hydrofilt polymerskikt och (D) ett underlag, varvid 10 utbredningsskiktet av pärlor innehäller (i) pärlor vars storlek ligger pä ett omräde 20 - 35 /xm, (ii) en fast koncentration av en receptor för den märkta liganden, 15 (iii) receptorerna har immobiliserats genom att de binds kovalent tili polymerpärlor, som är mindre än pär-lorna i punkt (i), och (iv) leukofärgämnebeteckningskomposition som om- fattar: 20 Komponent Torrviktsförhällande (omräde) > .* a) Triarylimidazolleuko- » ,· färgämne 55-80 ; b) Antioxidant 7 - 40 :· 25 c) Poly [poly (etenoxid) block-poly- t 'j (propenoxid) ]-icke-jonisk block- kopolymer 6 20 > · d) Alkylaryloxipoly(alkenoxid)-icke-joniskt ytaktivt ämne 1-16 ; 30
4. Element enligt nägot av patentkrav 1, 2 eller ’ 3, kännetecknat av att leukof ärgämnet är 4,5- j bis(4-dimetylaminofenyl)-2-(3,5-dimetyloxi-4- • hydroxifenyl)imidazol.
. 5. Element enligt nägot av patentkrav 1, 2 eller 35 3, kännetecknat av att det omfattar dimedon, [poly(polyetenoxid)-blockpoly(propenoxid)]kopolymer och 11309C isononylfenoxipolyglycidol med ca 10 upprepande, polymeri-serade glycidolenheter.
6. Element enligt nägot av patentkrav 1, 2 eller 3, kännetecknat av att det omfattar 4,5- 5 bis(4-dimetylaminofenyl)-2-(3,5-dimetoxi-4-hydroxifenyl)-imidazol, dimedon, poly[poly(etenoxid)-block-poly(propen-oxid)]-kopolymer och isononylfenoxipolyglycidol med ca 10 upprepande, polymeriserade glycidolenheter.
7. Förfarande för bestämning av en immunologiskt 10 reaktiv ligand i ett vattenhaltigt vätskeformigt prov, kännetecknat av att det omfattar steg i vilka man A. tar ett analyselement för torrimmunanalys enligt patentkrav 1, 2 eller 3, i vilket den märkta liganden 15 är enzymmärkt, B. bringar ett begränsat omräde av skiktet som omfattar den enzymmärkta liganden i kontakt med ett prov av det vätskeformiga provet, sä att antingen (i) en immobili-serad ligand/receptorkomplex eller (ii) en immobiliserad, 20 enzymmärkt ligand/receptorkomplex bildas, C. bringar ett begränsat omräde av skiktet som om- * fattar den enzymmärkta liganden i kontakt med en substrat- lösning för att katalysera färgutvecklingen, och : D. bestämmer ligandens koncentration kolorimet- :· 25 riskt. t 1 · J t · * · i »
FI954086A 1994-09-01 1995-08-31 Immunoanalyselement med stabila leukofärgöverdrag FI113090B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29972994 1994-09-01
US08/299,729 US5496702A (en) 1994-09-01 1994-09-01 Immunoassay elements having stable leuco dye coatings

Publications (3)

Publication Number Publication Date
FI954086A0 FI954086A0 (sv) 1995-08-31
FI954086A FI954086A (sv) 1996-03-02
FI113090B true FI113090B (sv) 2004-02-27

Family

ID=23156042

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954086A FI113090B (sv) 1994-09-01 1995-08-31 Immunoanalyselement med stabila leukofärgöverdrag

Country Status (10)

Country Link
US (1) US5496702A (sv)
EP (1) EP0699908B1 (sv)
JP (1) JP3574232B2 (sv)
KR (1) KR100372468B1 (sv)
AT (1) ATE197739T1 (sv)
AU (1) AU701176B2 (sv)
CA (1) CA2157203C (sv)
DE (1) DE69519459T2 (sv)
FI (1) FI113090B (sv)
NO (1) NO319458B1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928886A (en) * 1995-06-07 1999-07-27 Johnson & Johnson Clinical Diagnostics, Inc. Reduction in first slide bias and improved enzyme stability by incorporation of diaryl tellurides in the gravure layer of dry-film, immunoassay elements
US5895765A (en) * 1997-06-30 1999-04-20 Bayer Corporation Method for the detection of an analyte by immunochromatography
US6267722B1 (en) 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6394952B1 (en) * 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US7884120B2 (en) * 2002-08-19 2011-02-08 Lorus Therapeutics Inc. 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
DK1692113T3 (en) * 2003-11-14 2018-01-08 Lorus Therapeutics Inc ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES
AU2006250809B2 (en) * 2005-05-25 2011-05-12 Lorus Therapeutics Inc. 2-indolyl imidazo(4,5-D)phenanthroline derivatives and their use in the treatment of cancer
KR101343035B1 (ko) * 2008-12-22 2013-12-18 삼성전자 주식회사 제1수용체, 차단물질 및 제2수용체가 고정화된 고체 기판을포함하는 표적물질을 분석하기 위한 물품 및 그 용도
US9309247B2 (en) 2013-03-20 2016-04-12 Lorus Therapeutics Inc. 2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer
WO2015051302A1 (en) 2013-10-04 2015-04-09 Aptose Biosciences Inc. Compositions and methods for treating cancers
JP2021501203A (ja) 2017-10-30 2021-01-14 アプトース バイオサイエンシズ インコーポレイテッド がん治療用のアリールイミダゾール

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA557259A (en) 1955-02-23 1958-05-13 Canadian Kodak Co. Limited Multiple layer hopper for multiply coating a web
US4089747A (en) 1976-08-09 1978-05-16 Eastman Kodak Company Compositions for the detection of hydrogen peroxide
US4258001A (en) 1978-12-27 1981-03-24 Eastman Kodak Company Element, structure and method for the analysis or transport of liquids
JPS57101761A (en) 1980-12-17 1982-06-24 Konishiroku Photo Ind Co Ltd Analyzing element
US4552654A (en) * 1984-03-30 1985-11-12 Mansker William L Sample concentrating cable jig
US4670385A (en) * 1984-05-21 1987-06-02 Eastman Kodak Company Compositions and elements containing triarylmethane leuco dyes and methods using same
US4587211A (en) * 1985-02-01 1986-05-06 Minnesota Mining And Manufacturing Company Photothermographic stabilizers for syringaldazine leuco dyes
US4703002A (en) * 1985-05-01 1987-10-27 Eastman Kodak Company Method for preparing coating compositions containing an immunologically reactive species and elements containing same
US4670381A (en) * 1985-07-19 1987-06-02 Eastman Kodak Company Heterogeneous immunoassay utilizing horizontal separation in an analytical element
US5155024A (en) * 1986-07-10 1992-10-13 Eastman Kodak Company Binder composition and analytical element having stabilized peroxidase in layer containing the composition
US5024935A (en) * 1987-12-18 1991-06-18 Eastman Kodak Company Dye-providing composition, diagnostic test kit and their use in method for ligand determination using peroxidase labeled-receptor
JPH0833393B2 (ja) * 1988-03-14 1996-03-29 富士写真フイルム株式会社 乾式分析要素
DE59010009D1 (de) * 1989-10-27 1996-02-08 Ciba Geigy Ag Wässrige Farbstoff-Präparate
US5320946A (en) * 1990-07-05 1994-06-14 Eastman Kodak Company Method and element for assay of catechol and catechol generating substances
US5200315A (en) * 1990-07-25 1993-04-06 Eastman Kodak Company Particulate biologically active reagent containing polyoxyalkylene side chains, analytical element and methods for use of the reagent
US5358852A (en) * 1992-12-21 1994-10-25 Eastman Kodak Company Use of calcium in immunoassay for measurement of C-reactive protein
ATE176821T1 (de) * 1992-12-22 1999-03-15 Johnson & Johnson Clin Diag Immunoassay-elemente, die eine getrennte rezeptorschicht haben

Also Published As

Publication number Publication date
EP0699908A3 (sv) 1996-04-10
NO953423D0 (no) 1995-08-31
KR960010875A (ko) 1996-04-20
CA2157203A1 (en) 1996-03-02
AU3023695A (en) 1996-03-14
US5496702A (en) 1996-03-05
CA2157203C (en) 2006-07-18
JPH08178928A (ja) 1996-07-12
EP0699908B1 (en) 2000-11-22
JP3574232B2 (ja) 2004-10-06
EP0699908A2 (en) 1996-03-06
DE69519459D1 (de) 2000-12-28
FI954086A0 (sv) 1995-08-31
ATE197739T1 (de) 2000-12-15
AU701176B2 (en) 1999-01-21
KR100372468B1 (ko) 2003-09-26
FI954086A (sv) 1996-03-02
DE69519459T2 (de) 2001-03-22
NO953423L (no) 1996-03-04
NO319458B1 (no) 2005-08-15

Similar Documents

Publication Publication Date Title
EP0013156B1 (en) Particulate structure and element for analysis or transport of a liquid and method of making said element
US5714340A (en) Immunoassay elements having a receptor zone
US4430436A (en) Analytical element and method of use
US5968765A (en) Opaque reaction matrix for the analysis of the whole blood
US4381921A (en) Element, structure and method for the analysis or transport of liquids
FI113090B (sv) Immunoanalyselement med stabila leukofärgöverdrag
US4427632A (en) Analytical element
US4486537A (en) Analytical element and method of use
US4567024A (en) Analytical element
EP0116361A2 (en) Analytical element for dry analysis
KR100390103B1 (ko) 류코염료피복조성물,이의제조방법및당해조성물을함유하는소재
JP3696874B2 (ja) 水溶性ポリマー
EP0298473A2 (en) Analytical element for analysis of whole blood
JPH0219903B2 (sv)
JP2975248B2 (ja) 乾式イムノアッセイ分析要素
JPS5944660A (ja) 免疫測定用分析素子
JPS58123458A (ja) 分析素子
JPH0359458A (ja) 多層分析素子
JPS58204368A (ja) 分析素子
JPS58193460A (ja) 分析素子
JPH0519103B2 (sv)